One of the most comprehensive reports comparing the use of medicines in the UK with that in other countries has been published by the Department of Health. The report shows that the UK still lags behind comparable countries in Europe and elsewhere on its use of newer cancer treatments and medicines for chronic diseases such as rheumatoid arthritis, multiple sclerosis and dementia... (Source: Health News from Medical News Today)
Posted: 2010-07-28 06:00:00
More from this author:
Multiple Sclerosis: What Part Do Relapses Play In Severe Disability?
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Multiple Sclerosis Relapses and Severe Disability
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Stress, Fear, Anxiety and MS
From the Web > About.com Multiple Sclerosis: Most Popular Article
From the Web > About.com Multiple Sclerosis: Most Popular Article
Puusepp's sign—Clinical significance of a forgotten pyramidal sign
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Related Articles:
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure
From the Web > MedWorm: Multiple Sclerosis
Original paper Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
From the Web > MedWorm: Multiple Sclerosis
ABC-transporter Gene-polymorphisms Are Potential Pharmacogenetic Markers for Mitoxantrone Response in Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
